Држава: Малта
Језик: Енглески
Извор: Medicines Authority
VENLAFAXINE
Wockhardt UK Limited
N06AX16
VENLAFAXINE
PROLONGED-RELEASE CAPSULE
VENLAFAXINE 150 mg
POM
PSYCHOANALEPTICS
Authorised
2009-10-21
PACKAGE LEAFLET: INFORMATION FOR THE USER TONPULAR XL 75MG PROLONGED-RELEASE HARD CAPSULES TONPULAR XL 150MG PROLONGED-RELEASE HARD CAPSULES Venlafaxine Hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm hem, even if their signs of illness are he same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. WHAT TONPULAR XL IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE TONPULAR XL 3. HOW TO TAKE TONPULAR XL 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE TONPULAR XL 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT TONPULAR XL IS AND WHAT IT IS USED FOR Tonpular XL contains the active substance venlafaxine hydrochloride. Tonpular XL is an antidepressant that belongs to a group of medicines called Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs). Everyone has substances in their brain called serotonin and noradrenaline. It is thought that people suffering from depression (and associated conditions) have less of these substances compared to people who do not have depression (and associated conditions). It is not fully understood how antidepressants work, but they may help by increasing the amount of serotonin and noradrenaline in the brain. TONPULAR XL IS USED TO TREAT: • DEPRESSION (INCLUDING ANXIETY SYMPTOMS) If you are depressed, you may have feelings of extreme sadness. These feelings can interfere with your everyday life and last a long time (e g. weeks and months). • PANIC DISORDER (PANIC ATTACKS) Venlafaxine, which is contained in Tonpular XL, is also au horised to treat other conditions which are not men ioned in his leaflet. Ask your doctor or pharmacist if Прочитајте комплетан документ
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Tonpular XL 150mg Prolonged-Release Hard Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each prolonged release hard capsule contains 169.7mg of venlafaxine hydrochloride, equivalent to 150mg of venlafaxine. Excipients: Sunset yellow FCF (E110) 0.2286mg Tartrazine (E102) 0.0304mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Prolonged-release capsule, hard. Size '0' hard gelatin capsule with orange opaque cap and orange opaque body filled with white to off white pellets. The capsule is imprinted with _W_ 718 on cap in white colour. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of major depressive episodes. For prevention of recurrence of major depressive episodes. Treatment of panic disorder, with or without agoraphobia. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Major depressive episodes _ The recommended starting dose for prolonged-release venlafaxine is 75 mg given once daily. Patients not responding to the initial 75 mg/day dose may benefit from dose increases up to a maximum dose of 375 mg/day. Dosage increases can be made at intervals of 2 weeks or more. If clinically warranted due to symptom severity, dose increases can be made at more frequent intervals, but not less than 4 days. Because of the risk of dose-related adverse effects, dose increments should be made only after a clinical evaluation (see section 4.4). The lowest effective dose should be maintained. Patients should be treated for a sufficient period of time, usually several months or longer. Treatment should be reassessed regularly on a case-by-case basis. Longer-term treatment may also be appropriate for prevention of recurrence of major depressive episodes (MDE). In most of the cases, the recommended dose in prevention of recurrence of MDE is the same as the one used during the current episode. _ _ Antidepressive medicinal products should continue for at least six months following remission. _Panic disorder _ It is recomm Прочитајте комплетан документ